Molecular, genetic and lifecourse epidemiology. (360G-Wellcome-093847_Z_10_Z)

£143,090

1. I hypothesize that common upstream regulatory pathways of CREB/AhR regulate FSCN1 promoter activity in carcinomas. 2. I hypothesize that CREB/AhR regulates the expression of genes involved in the cancer invasion "program" which are associated with prostate cancer progression. 3. I hypothesize that CREB/AhR and miRNAs act in concert to regulate fascin-1 protein levels in carcinomas. 4. 1 hypothesize that the up-regulation of fascin-1 protein is associated with prostate cancer progression. In addition, I hypothesize that the expression or activation status of regulators of fascin-1 expression such as CREB/AhR and miRNAs are associated with prostate cancer progression. I will test my hypotheses by applying a combination of cell biology and epidemiology approaches, in order to both understand the regulation of FSCN1 in cancer and the translational potential of FSCN1 and its regulators as potential prognostic cancer biomarkers. My unique first year training programme has equipped me with the wide set of skills I require to combine both approaches within a single, unifying PhD project.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 143090
Applicant Surname Tan
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2010-07-13T00:00:00+00:00
Financial Year 2009/10
Grant Programme: Title PhD Studentship (Basic)
Internal ID 093847/Z/10/Z
Lead Applicant Dr Vanessa Tan
Partnership Value 143090
Planned Dates: End Date 2014-10-03T00:00:00+00:00
Planned Dates: Start Date 2010-10-04T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South West
Sponsor(s) Prof George Davey Smith